Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease

被引:51
作者
Takara, M [1 ]
Komiya, I [1 ]
Kinjo, Y [1 ]
Tomoyose, T [1 ]
Yamashiro, AS [1 ]
Akamine, H [1 ]
Masuda, M [1 ]
Takasu, N [1 ]
机构
[1] Univ Ryukyus, Sch Med, Dept Internal Med 2, Okinawa 9030215, Japan
关键词
D O I
10.2337/diacare.23.7.975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - We studied the association between type I diabetes with autoimmune thyroid disease (AITD) and A/G allele polymorphism in ex:on 1 of the CTLA-4 gene in a Japanese population. RESEARCH DESIGN AND METHODS - We studied 74 Japanese type 1 diabetic patients with or without AITD and 107 normal subjects to identify the association between CTLA-4 polymorphism and type 1 diabetes using polymerase chain reaction-restriction fragment length polymorphism analysis. RESULTS - The frequency of the CTLA-4 G allele differed significantly between the type 1 diabetic patients (61%) and the normal control subjects (48%) (P = 0.016). The difference in the CTLA-4 G allele became greater between patients with a younger age of onset of type 1 diabetes (age at onset <30 years) and the normal control subjects (64% and 48%, respectively). However, the frequency of the CTLA-4 G allele did not differ between type 1 diabetic patients with younger and older age of onset (64% vs. 57%). The G allele frequencies in the patients with younger-onset type 1 diabetes and AITD increased more than in the control patients (P = 0.025). These differences reflected a significant increase in the frequency of G/G genotype-that is, 54% in those with younger-onset type 1 diabetes and AITD, 39% in those without AITD, and 28% in control subjects. CONCLUSIONS - An association was detected between the CTLA-4 gene polymorphism and younger-onset type 1 diabetes with AITD. The G variant was suggested to be genetically linked to AITD-associated type 1 diabetes of younger onset in this Japanese population. The defect in these patients presumably lies in a T-cell-mediated autoimmune mechanism.
引用
收藏
页码:975 / 978
页数:4
相关论文
共 25 条
[1]  
Akamine H, 1997, DIABETIC MED, V14, P778, DOI 10.1002/(SICI)1096-9136(199709)14:9<778::AID-DIA461>3.0.CO
[2]  
2-7
[3]   Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers [J].
Akamine, H ;
Takasu, N ;
Komiya, I ;
Ishikawa, K ;
Shinjyo, T ;
Nakachi, K ;
Masuda, M .
CLINICAL ENDOCRINOLOGY, 1996, 45 (04) :461-466
[4]   Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves disease and Hashimoto's thyroiditis) in the Japanese population [J].
Awata, T ;
Kurihara, S ;
Iitaka, M ;
Takei, S ;
Inoue, I ;
Ishii, C ;
Negishi, K ;
Izumida, T ;
Yoshida, Y ;
Hagura, R ;
Kuzuya, N ;
Kanazawa, Y ;
Katayama, S .
DIABETES, 1998, 47 (01) :128-129
[5]   Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type 2-mediated autoimmune disease [J].
Biancone, L ;
Andres, G ;
Ahn, H ;
Lim, A ;
Dai, C ;
Noelle, R ;
Yagita, H ;
DeMartino, C ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1473-1481
[6]   PROGRESSION TO TYPE-I DIABETES IN AUTOIMMUNE ENDOCRINE PATIENTS WITH ISLET CELL ANTIBODIES [J].
BOSI, E ;
BECKER, F ;
BONIFACIO, E ;
WAGNER, R ;
COLLINS, P ;
GALE, EAM ;
BOTTAZZO, GF .
DIABETES, 1991, 40 (08) :977-984
[7]   CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis [J].
Braun, J ;
Donner, H ;
Siegmund, T ;
Walfish, PG ;
Usadel, KH ;
Badenhoop, K .
TISSUE ANTIGENS, 1998, 51 (05) :563-566
[8]   An Mse I RFLP in the human CTLA4 promotor [J].
Deichmann, K ;
Heinzmann, A ;
Bruggenolte, E ;
Forster, J ;
Kuehr, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :817-818
[9]   No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM [J].
Djilali-Saiah, I ;
Larger, E ;
Harfouch-Hammoud, E ;
Timsit, J ;
Clerc, J ;
Bertin, E ;
Assan, R ;
Boitard, C ;
Bach, JF ;
Caillat-Zucman, S .
DIABETES, 1998, 47 (01) :125-127
[10]   CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [J].
Donner, H ;
Rau, H ;
Walfish, PG ;
Braun, J ;
Siegmund, T ;
Finke, R ;
Herwig, J ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :143-146